Published date: 30 November 2017
Last edited date: 30 November 2017
This notice was replaced on 30 November 2017
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 30 November 2017)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Immunoglobulins - 33651520
Location of contract
Wales, Northern Ireland, Isle of Man, Channel Islands
Value of contract
£0
Procurement reference
CM_PHV_15_5475
Published date
30 November 2017
Closing date
5 June 2017
Contract start date
1 May 2018
Contract end date
30 April 2020
Contract type
Supply contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The provision of human Normal Immunoglobulin, Rabies Immunoglobulin, Varicella Zoster Immunoglobulin andHepatitis B Immunoglobulin both 200 and 500 international units. Deliveries will be required over a period of 2years, with an option to extend for up to an additional 12 months.
More information
Attachments
-
- ITO-OJEU Docs_Immunoglobulins.zip
- Contract notice
- ITO_OJEU Docs_Immunoglobulins
Additional text
-
This publication is to notify the market of a current opportunity that exists to supply immunogloblins. Attachments include a copy of the published OJEU notice along with the ITO documents that have been published via the Bravo e-tendering portal.
About the buyer
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
All content is available under the
